Bicocca Open Archive

Logo unimib boa
SALA, GESSICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.092
EU - Europa 6.128
AS - Asia 6.084
SA - Sud America 906
Continente sconosciuto - Info sul continente non disponibili 491
AF - Africa 158
OC - Oceania 10
Totale 27.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.348
SG - Singapore 1.993
IT - Italia 1.857
CN - Cina 1.386
VN - Vietnam 924
DE - Germania 825
RU - Federazione Russa 719
BR - Brasile 674
HK - Hong Kong 659
SE - Svezia 618
CA - Canada 541
IE - Irlanda 401
GB - Regno Unito 382
UA - Ucraina 317
IN - India 260
FR - Francia 222
FI - Finlandia 176
AT - Austria 148
BD - Bangladesh 122
KR - Corea 111
PL - Polonia 90
TR - Turchia 83
NL - Olanda 82
AR - Argentina 80
ES - Italia 78
ID - Indonesia 71
IQ - Iraq 71
MX - Messico 68
JP - Giappone 67
PK - Pakistan 59
DK - Danimarca 50
PH - Filippine 47
BE - Belgio 43
ZA - Sudafrica 41
IR - Iran 39
CO - Colombia 35
EC - Ecuador 33
CR - Costa Rica 28
VE - Venezuela 27
EG - Egitto 25
SA - Arabia Saudita 25
CH - Svizzera 22
IL - Israele 22
JM - Giamaica 22
UZ - Uzbekistan 22
KE - Kenya 20
MY - Malesia 19
LT - Lituania 18
ET - Etiopia 16
HN - Honduras 16
PY - Paraguay 16
CL - Cile 15
MA - Marocco 15
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
JO - Giordania 11
NI - Nicaragua 10
PE - Perù 10
PT - Portogallo 10
EU - Europa 9
GT - Guatemala 9
NP - Nepal 9
TW - Taiwan 9
DZ - Algeria 8
EE - Estonia 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
AU - Australia 7
GR - Grecia 7
KZ - Kazakistan 7
OM - Oman 7
PR - Porto Rico 7
SY - Repubblica araba siriana 7
TN - Tunisia 7
BB - Barbados 6
CW - ???statistics.table.value.countryCode.CW??? 6
RO - Romania 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
LB - Libano 5
LV - Lettonia 5
LY - Libia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
GE - Georgia 4
KG - Kirghizistan 4
PA - Panama 4
PS - Palestinian Territory 4
AL - Albania 3
BZ - Belize 3
CY - Cipro 3
MN - Mongolia 3
MU - Mauritius 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
Totale 27.343
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.609
Ashburn 1.538
Singapore 1.177
San Jose 833
Woodbridge 680
Hong Kong 629
Milan 589
Chandler 545
Frankfurt am Main 522
Houston 511
Council Bluffs 405
Fairfield 392
Dublin 384
Jacksonville 353
New York 326
Toronto 323
Wilmington 323
Santa Clara 311
Dallas 285
Ho Chi Minh City 278
Dearborn 265
Los Angeles 251
Hanoi 210
Beijing 191
Seattle 178
Chicago 153
Princeton 152
Cambridge 139
Vienna 129
Rome 124
The Dalles 120
Shanghai 112
Hefei 107
Boardman 96
Nanjing 96
Columbus 90
Seoul 87
Phoenix 81
Buffalo 80
Lauterbourg 78
São Paulo 72
Helsinki 69
Lachine 61
Moscow 58
Altamura 54
Munich 54
Guangzhou 52
Da Nang 50
Orem 48
Jakarta 47
Lawrence 47
London 47
Kraków 44
North Bergen 44
Turin 44
Montreal 43
Brussels 41
Tokyo 41
Brooklyn 38
Chennai 38
Atlanta 37
Fremont 37
Haiphong 35
San Diego 34
Changsha 33
San Francisco 33
Shenyang 33
Pisa 32
Denver 31
Newark 30
Warsaw 30
Secaucus 29
Nanchang 28
Turku 28
Jinan 27
Tianjin 27
Dong Ket 26
Rio de Janeiro 26
Monza 25
Pune 25
Andover 24
Baghdad 24
Ottawa 23
Zhengzhou 23
Amsterdam 22
Biên Hòa 22
Falls Church 22
Hebei 22
Piscataway 22
Washington 22
Boston 21
Grafing 21
Lahore 21
Zurich 21
Manchester 20
Naples 20
New Delhi 20
Philadelphia 20
Poplar 20
Belo Horizonte 19
Totale 16.779
Salva come PNG Salva come JPEG
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 699
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 583
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 544
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 501
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 483
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 467
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 444
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 426
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 425
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 404
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 398
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 395
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 387
New insights into the genetic etiology of Alzheimer's disease and related dementias 383
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 382
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 381
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 381
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 377
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 377
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 376
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 371
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 366
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 364
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 359
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 353
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 351
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 350
Reduced platelet glutamate uptake in Parkinson's disease 349
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 349
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 349
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 348
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 342
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 339
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 339
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 327
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 323
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 321
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 320
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 314
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 313
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 311
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 307
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 305
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 304
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 302
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 301
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 298
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 296
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 289
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 288
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 288
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 287
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 282
the MonzALS collaborative network 282
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 282
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 281
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 281
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 281
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 280
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 277
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 277
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 272
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 271
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 262
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 254
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 252
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 245
Macroautophagy is not altered in ALS lymphomonocytes 242
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 241
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 240
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 233
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 231
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 217
Assessing glutamatergic function and dysfunction in peripheral tissues 214
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 210
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 207
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 206
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 201
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 197
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 191
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 189
Whole-blood global DNA methylation and phenotypic variability in ALS 188
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 188
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 183
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 169
Platelets 157
Multicenter Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS BASIC) 147
Effects of multidomain interventions on health outcomes in older adults: A systematic review and meta-analysis 88
Pragmatic cluster-randomised trial of a multidomain intervention to prevent hospital-acquired disability: the OPTIMAge-IT study protocol 88
NMR-based metabolic profiling of human plasma for the identification of biomarkers associated with ageing 83
Cholesterol in amyotrophic lateral sclerosis: a bystander, a biomarker, or a target? 69
Spectroscopic approaches for the identification of biomolecular signatures of ageing and age-related processes 65
Identification of ageing-related biomarkers through NMR metabolic profiling of human plasma. 56
Dementia risk factors and biomarkers in subjective cognitive decline: real world evidence from the monza brain health service 54
Totale 27.869
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022688 0 0 0 0 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/20253.377 170 407 276 135 253 185 161 139 318 549 278 506
2025/20269.574 1.107 571 689 934 1.000 463 1.474 403 908 893 566 566
2026/20273.305 344 470 1.059 1.358 74 0 0 0 0 0 0 0
Totale 27.869